Report Detail

Request for Sample of this report

Pharma & Healthcare Global Injectable IVF Medications Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM4583514
    • |
  • 29 March, 2024
    • |
  • Global
    • |
  • 113 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Injectable IVF Medications market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Injectable IVF (In Vitro Fertilization) medications are pharmaceutical drugs administered via injection to stimulate and regulate a woman's reproductive system during the fertility treatment process. These medications typically include hormones such as gonadotropins and follicle-stimulating hormone (FSH), which encourage the development of multiple eggs within the ovaries. Additionally, other drugs like human chorionic gonadotropin (hCG) are used to trigger the final maturation of eggs before retrieval. Injectable IVF medications play a crucial role in controlling the ovulation process, optimizing egg production, and enhancing the chances of successful fertilization during assisted reproductive technologies.
The fertility preservation and infertility treatment market has witnessed significant growth in recent years, driven by factors such as increasing infertility rates, delayed pregnancies, advancements in assisted reproductive technologies (ART), and growing awareness. Fertility preservation technologies, including egg freezing and sperm banking, have gained popularity among individuals seeking to preserve their reproductive potential. In the infertility treatment segment, in vitro fertilization (IVF), intrauterine insemination (IUI), and other ART procedures have become mainstream options. Future developments are anticipated in areas such as personalized medicine, gene editing technologies, and improved success rates in ART procedures. The market is likely to see ongoing advancements, innovations, and collaborations aimed at addressing infertility challenges and expanding the range of options available to individuals and couples.
The Global Info Research report includes an overview of the development of the Injectable IVF Medications industry chain, the market status of IVF and Embryo Transfer (Follicle Stimulating Hormone (FSH), Luteinizing Hormone (LH)), Infertility Treatment (Follicle Stimulating Hormone (FSH), Luteinizing Hormone (LH)), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Injectable IVF Medications.
Regionally, the report analyzes the Injectable IVF Medications markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Injectable IVF Medications market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Injectable IVF Medications market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Injectable IVF Medications industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Follicle Stimulating Hormone (FSH), Luteinizing Hormone (LH)).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Injectable IVF Medications market.
Regional Analysis: The report involves examining the Injectable IVF Medications market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Injectable IVF Medications market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Injectable IVF Medications:
Company Analysis: Report covers individual Injectable IVF Medications manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Injectable IVF Medications This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (IVF and Embryo Transfer, Infertility Treatment).
Technology Analysis: Report covers specific technologies relevant to Injectable IVF Medications. It assesses the current state, advancements, and potential future developments in Injectable IVF Medications areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Injectable IVF Medications market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Injectable IVF Medications market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Follicle Stimulating Hormone (FSH)
Luteinizing Hormone (LH)
Human Chorionic Gonadotropin (hCG)
Others
Market segment by Application
IVF and Embryo Transfer
Infertility Treatment
Major players covered
Gonal-F (Merck)
Follistim (Organon)
Bravelle (Ferring)
Menopur (Ferring)
Fostimon (IBSA)
Puregon (Organon)
BEMFOLA (Gedeon Richter)
Novarel (Ferring)
Ovidrel (Merck)
Synarel (Pfizer Medical)
Follitrope (LG Chem)
Profasi (Serum Institute Of India)
Livzon
GenSci
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Injectable IVF Medications product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Injectable IVF Medications, with price, sales, revenue and global market share of Injectable IVF Medications from 2019 to 2024.
Chapter 3, the Injectable IVF Medications competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Injectable IVF Medications breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Injectable IVF Medications market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Injectable IVF Medications.
Chapter 14 and 15, to describe Injectable IVF Medications sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Injectable IVF Medications
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Injectable IVF Medications Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Follicle Stimulating Hormone (FSH)
    • 1.3.3 Luteinizing Hormone (LH)
    • 1.3.4 Human Chorionic Gonadotropin (hCG)
    • 1.3.5 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Injectable IVF Medications Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 IVF and Embryo Transfer
    • 1.4.3 Infertility Treatment
  • 1.5 Global Injectable IVF Medications Market Size & Forecast
    • 1.5.1 Global Injectable IVF Medications Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Injectable IVF Medications Sales Quantity (2019-2030)
    • 1.5.3 Global Injectable IVF Medications Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Gonal-F (Merck)
    • 2.1.1 Gonal-F (Merck) Details
    • 2.1.2 Gonal-F (Merck) Major Business
    • 2.1.3 Gonal-F (Merck) Injectable IVF Medications Product and Services
    • 2.1.4 Gonal-F (Merck) Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Gonal-F (Merck) Recent Developments/Updates
  • 2.2 Follistim (Organon)
    • 2.2.1 Follistim (Organon) Details
    • 2.2.2 Follistim (Organon) Major Business
    • 2.2.3 Follistim (Organon) Injectable IVF Medications Product and Services
    • 2.2.4 Follistim (Organon) Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Follistim (Organon) Recent Developments/Updates
  • 2.3 Bravelle (Ferring)
    • 2.3.1 Bravelle (Ferring) Details
    • 2.3.2 Bravelle (Ferring) Major Business
    • 2.3.3 Bravelle (Ferring) Injectable IVF Medications Product and Services
    • 2.3.4 Bravelle (Ferring) Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Bravelle (Ferring) Recent Developments/Updates
  • 2.4 Menopur (Ferring)
    • 2.4.1 Menopur (Ferring) Details
    • 2.4.2 Menopur (Ferring) Major Business
    • 2.4.3 Menopur (Ferring) Injectable IVF Medications Product and Services
    • 2.4.4 Menopur (Ferring) Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Menopur (Ferring) Recent Developments/Updates
  • 2.5 Fostimon (IBSA)
    • 2.5.1 Fostimon (IBSA) Details
    • 2.5.2 Fostimon (IBSA) Major Business
    • 2.5.3 Fostimon (IBSA) Injectable IVF Medications Product and Services
    • 2.5.4 Fostimon (IBSA) Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Fostimon (IBSA) Recent Developments/Updates
  • 2.6 Puregon (Organon)
    • 2.6.1 Puregon (Organon) Details
    • 2.6.2 Puregon (Organon) Major Business
    • 2.6.3 Puregon (Organon) Injectable IVF Medications Product and Services
    • 2.6.4 Puregon (Organon) Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Puregon (Organon) Recent Developments/Updates
  • 2.7 BEMFOLA (Gedeon Richter)
    • 2.7.1 BEMFOLA (Gedeon Richter) Details
    • 2.7.2 BEMFOLA (Gedeon Richter) Major Business
    • 2.7.3 BEMFOLA (Gedeon Richter) Injectable IVF Medications Product and Services
    • 2.7.4 BEMFOLA (Gedeon Richter) Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 BEMFOLA (Gedeon Richter) Recent Developments/Updates
  • 2.8 Novarel (Ferring)
    • 2.8.1 Novarel (Ferring) Details
    • 2.8.2 Novarel (Ferring) Major Business
    • 2.8.3 Novarel (Ferring) Injectable IVF Medications Product and Services
    • 2.8.4 Novarel (Ferring) Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Novarel (Ferring) Recent Developments/Updates
  • 2.9 Ovidrel (Merck)
    • 2.9.1 Ovidrel (Merck) Details
    • 2.9.2 Ovidrel (Merck) Major Business
    • 2.9.3 Ovidrel (Merck) Injectable IVF Medications Product and Services
    • 2.9.4 Ovidrel (Merck) Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Ovidrel (Merck) Recent Developments/Updates
  • 2.10 Synarel (Pfizer Medical)
    • 2.10.1 Synarel (Pfizer Medical) Details
    • 2.10.2 Synarel (Pfizer Medical) Major Business
    • 2.10.3 Synarel (Pfizer Medical) Injectable IVF Medications Product and Services
    • 2.10.4 Synarel (Pfizer Medical) Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Synarel (Pfizer Medical) Recent Developments/Updates
  • 2.11 Follitrope (LG Chem)
    • 2.11.1 Follitrope (LG Chem) Details
    • 2.11.2 Follitrope (LG Chem) Major Business
    • 2.11.3 Follitrope (LG Chem) Injectable IVF Medications Product and Services
    • 2.11.4 Follitrope (LG Chem) Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Follitrope (LG Chem) Recent Developments/Updates
  • 2.12 Profasi (Serum Institute Of India)
    • 2.12.1 Profasi (Serum Institute Of India) Details
    • 2.12.2 Profasi (Serum Institute Of India) Major Business
    • 2.12.3 Profasi (Serum Institute Of India) Injectable IVF Medications Product and Services
    • 2.12.4 Profasi (Serum Institute Of India) Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Profasi (Serum Institute Of India) Recent Developments/Updates
  • 2.13 Livzon
    • 2.13.1 Livzon Details
    • 2.13.2 Livzon Major Business
    • 2.13.3 Livzon Injectable IVF Medications Product and Services
    • 2.13.4 Livzon Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Livzon Recent Developments/Updates
  • 2.14 GenSci
    • 2.14.1 GenSci Details
    • 2.14.2 GenSci Major Business
    • 2.14.3 GenSci Injectable IVF Medications Product and Services
    • 2.14.4 GenSci Injectable IVF Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 GenSci Recent Developments/Updates

3 Competitive Environment: Injectable IVF Medications by Manufacturer

  • 3.1 Global Injectable IVF Medications Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Injectable IVF Medications Revenue by Manufacturer (2019-2024)
  • 3.3 Global Injectable IVF Medications Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Injectable IVF Medications by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Injectable IVF Medications Manufacturer Market Share in 2023
    • 3.4.2 Top 6 Injectable IVF Medications Manufacturer Market Share in 2023
  • 3.5 Injectable IVF Medications Market: Overall Company Footprint Analysis
    • 3.5.1 Injectable IVF Medications Market: Region Footprint
    • 3.5.2 Injectable IVF Medications Market: Company Product Type Footprint
    • 3.5.3 Injectable IVF Medications Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Injectable IVF Medications Market Size by Region
    • 4.1.1 Global Injectable IVF Medications Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Injectable IVF Medications Consumption Value by Region (2019-2030)
    • 4.1.3 Global Injectable IVF Medications Average Price by Region (2019-2030)
  • 4.2 North America Injectable IVF Medications Consumption Value (2019-2030)
  • 4.3 Europe Injectable IVF Medications Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Injectable IVF Medications Consumption Value (2019-2030)
  • 4.5 South America Injectable IVF Medications Consumption Value (2019-2030)
  • 4.6 Middle East and Africa Injectable IVF Medications Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Injectable IVF Medications Sales Quantity by Type (2019-2030)
  • 5.2 Global Injectable IVF Medications Consumption Value by Type (2019-2030)
  • 5.3 Global Injectable IVF Medications Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Injectable IVF Medications Sales Quantity by Application (2019-2030)
  • 6.2 Global Injectable IVF Medications Consumption Value by Application (2019-2030)
  • 6.3 Global Injectable IVF Medications Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Injectable IVF Medications Sales Quantity by Type (2019-2030)
  • 7.2 North America Injectable IVF Medications Sales Quantity by Application (2019-2030)
  • 7.3 North America Injectable IVF Medications Market Size by Country
    • 7.3.1 North America Injectable IVF Medications Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Injectable IVF Medications Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Injectable IVF Medications Sales Quantity by Type (2019-2030)
  • 8.2 Europe Injectable IVF Medications Sales Quantity by Application (2019-2030)
  • 8.3 Europe Injectable IVF Medications Market Size by Country
    • 8.3.1 Europe Injectable IVF Medications Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Injectable IVF Medications Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Injectable IVF Medications Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Injectable IVF Medications Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Injectable IVF Medications Market Size by Region
    • 9.3.1 Asia-Pacific Injectable IVF Medications Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Injectable IVF Medications Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Injectable IVF Medications Sales Quantity by Type (2019-2030)
  • 10.2 South America Injectable IVF Medications Sales Quantity by Application (2019-2030)
  • 10.3 South America Injectable IVF Medications Market Size by Country
    • 10.3.1 South America Injectable IVF Medications Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Injectable IVF Medications Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Injectable IVF Medications Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Injectable IVF Medications Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Injectable IVF Medications Market Size by Country
    • 11.3.1 Middle East & Africa Injectable IVF Medications Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Injectable IVF Medications Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Injectable IVF Medications Market Drivers
  • 12.2 Injectable IVF Medications Market Restraints
  • 12.3 Injectable IVF Medications Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Injectable IVF Medications and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Injectable IVF Medications
  • 13.3 Injectable IVF Medications Production Process
  • 13.4 Injectable IVF Medications Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Injectable IVF Medications Typical Distributors
  • 14.3 Injectable IVF Medications Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Injectable IVF Medications. Industry analysis & Market Report on Injectable IVF Medications is a syndicated market report, published as Global Injectable IVF Medications Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Injectable IVF Medications market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo